In the subgroup of 15 NAFLD patients for whom liver biopsy was available, we explored the hepatic expression of ACE2 and TMPRSS2 by Western blot (native proteins) and IHC analysis. This evidence concerns the gene TMPRSS2 and metabolic dysfunction-associated steatotic liver disease.